(19)
(11) EP 4 297 646 A1

(12)

(43) Date of publication:
03.01.2024 Bulletin 2024/01

(21) Application number: 22710532.7

(22) Date of filing: 24.02.2022
(51) International Patent Classification (IPC): 
A61B 5/145(2006.01)
A61B 5/0205(2006.01)
A61B 5/00(2006.01)
A61B 5/11(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 5/14532; A61B 5/14546; A61B 5/4866; A61B 5/4875; A61B 5/14539; A61B 5/02055; A61B 5/1118; A61B 5/4806; A61B 5/681; A61B 5/6898; A61B 5/14503; A61B 5/0031; A61B 2560/0219; A61B 5/0075
(86) International application number:
PCT/EP2022/054711
(87) International publication number:
WO 2022/180184 (01.09.2022 Gazette 2022/35)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.02.2021 US 202117183921

(71) Applicant: Indigo Diabetes N.V.
9052 Gent (BE)

(72) Inventors:
  • ORDONEZ ORELLANA, Juan Sebastian
    9000 Gent (BE)
  • DELBEKE, DanaĆ«
    9050 Gentbrugge (BE)

(74) Representative: Winger 
Mouterij 16 bus 101
3190 Boortmeerbeek
3190 Boortmeerbeek (BE)

   


(54) CONTINUOUS HEALTH MONITORING SYSTEM